UPLC-MS/MS determination of doxazosine in human plasma

被引:38
作者
Al-Dirbashi, Osama Y.
Aboul-Enein, Hassan Y.
Jacob, Minnie
Al-Qahtani, Khalid
Rashed, Mohamed S.
机构
[1] King Faisal Specialist Hosp & Res Ctr, Natl Lab Newborn Screening, Riyadh 11211, Saudi Arabia
[2] Natl Res Ctr, Pharmaceut & Med Chem Dept, Cairo 12311, Egypt
关键词
doxazosine; UPLC; UPLC-MS; MS;
D O I
10.1007/s00216-006-0553-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive, selective and rapid method for the analysis of doxazosine (DOX) in human plasma based on ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) is described. DOX and tamsulosin, used as an internal standard (IS), were extracted by liquid-liquid extraction, and the chromatography was performed on a C18 UPLC column packed with 1.7 mu m particles. The total run time was 2 min. Detection was achieved by the multiple reaction monitoring of the following transitions: m/z 452 -> 344 and m/z 409 -> 228 for DOX and IS, respectively. Transitions of m/z 452 -> 247 and m/z 409 -> 271 were also collected for confirmation purposes. The calibration curve based on peak area ratio was linear up to at least 100 ng ml(-1), with a detection limit of 0.02 ng ml(-1) (a signal-to-noise ratio of 3). The method showed satisfactory reproducibility, and the short-term stability of the analyte was assessed. The method was successfully applied to the analysis of DOX in human plasma.
引用
收藏
页码:1439 / 1443
页数:5
相关论文
共 19 条
[1]   Pulse polarographic (constant and increasing) determinations of doxazosin in pharmaceutical tablets [J].
Altiokka, G ;
Tuncel, M .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 17 (01) :169-175
[2]   Cathodic stripping voltammetric determination of doxazosin in urine and pharmaceutical tablets using carbon paste electrodes [J].
Arranz, A ;
deBetono, SF ;
Moreda, JM ;
Cid, A ;
Arranz, JF .
ANALYST, 1997, 122 (08) :849-854
[3]   Stability-indicating methods for the determination of doxazosin mezylate and celecoxib [J].
Bebawy, LI ;
Moustafa, AA ;
Abo-Talib, NF .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 27 (05) :779-793
[4]  
Chung M, 1999, BRIT J CLIN PHARMACO, V48, P678
[5]   Improving LC-MS sensitivity through increases in chromatographic performance: Comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS [J].
Churchwell, MI ;
Twaddle, NC ;
Meeker, LR ;
Doerge, DR .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 825 (02) :134-143
[6]   DOXAZOSIN DETERMINATION BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY USING FLUORESCENCE DETECTION [J].
COWLISHAW, MG ;
SHARMAN, JR .
JOURNAL OF CHROMATOGRAPHY, 1985, 344 (NOV) :403-407
[7]   LIQUID-CHROMATOGRAPHIC ANALYSIS OF DOXAZOSIN IN HUMAN-SERUM WITH MANUAL AND ROBOTIC SAMPLE PREPARATION [J].
FOUDA, HG ;
TWOMEY, TM ;
SCHNEIDER, RP .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1988, 26 (11) :570-573
[8]   DOXAZOSIN FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-RESPONSE MULTICENTER STUDY [J].
GILLENWATER, JY ;
CONN, RL ;
CHRYSANT, SG ;
ROY, J ;
GAFFNEY, M ;
ICE, K ;
DIAS, N .
JOURNAL OF UROLOGY, 1995, 154 (01) :110-115
[9]   Doxazosin gastrointestinal therapeutic system: A review of its use in benign prostatic hyperplasia [J].
Goldsmith, DR ;
Plosker, GL .
DRUGS, 2005, 65 (14) :2037-2047
[10]  
Hoogerbrugge N, 2002, NETH J MED, V60, P354